209 related articles for article (PubMed ID: 28979738)
1. Role of Angiopoietins and Tie-2 in Diabetic Retinopathy.
Khalaf N; Helmy H; Labib H; Fahmy I; El Hamid MA; Moemen L
Electron Physician; 2017 Aug; 9(8):5031-5035. PubMed ID: 28979738
[TBL] [Abstract][Full Text] [Related]
2. Effects of laser photocoagulation on serum angiopoietin-1, angiopoietin-2, angiopoietin-1/angiopoietin-2 ratio, and soluble angiopoietin receptor Tie-2 levels in type 2 diabetic patients with proliferative diabetic retinopathy.
You QY; Zhuge FY; Zhu QQ; Si XW
Int J Ophthalmol; 2014; 7(4):648-53. PubMed ID: 25161936
[TBL] [Abstract][Full Text] [Related]
3. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY
Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
[TBL] [Abstract][Full Text] [Related]
4. The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.
Mohan JS; Lip PL; Blann AD; Bareford D; Lip GY
Br J Ophthalmol; 2005 Jul; 89(7):815-9. PubMed ID: 15965157
[TBL] [Abstract][Full Text] [Related]
5. Aqueous Levels of Angiopoietin-like 4 and Semaphorin 3E Correlate with Nonperfusion Area and Macular Volume in Diabetic Retinopathy.
Kwon SH; Shin JP; Kim IT; Park DH
Ophthalmology; 2015 May; 122(5):968-75. PubMed ID: 25687026
[TBL] [Abstract][Full Text] [Related]
6. ANGPTL-4 correlates with vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Lu Q; Zou W; Chen B; Zou C; Zhao M; Zheng Z
Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1281-8. PubMed ID: 26483143
[TBL] [Abstract][Full Text] [Related]
7. Serum Ang-1/Ang-2 ratio may be a promising biomarker for evaluating severity of diabetic retinopathy.
Wang Y; Fang J; Niu T; Xing X; Wang H; Shi X; Liu Y; Liu X; Chen C; Liu K
Graefes Arch Clin Exp Ophthalmol; 2023 Jan; 261(1):49-55. PubMed ID: 35838805
[TBL] [Abstract][Full Text] [Related]
8. Expression of angiopoietin-like protein 8 correlates with VEGF in patients with proliferative diabetic retinopathy.
Lu Q; Lu L; Chen W; Lu P
Graefes Arch Clin Exp Ophthalmol; 2017 Aug; 255(8):1515-1523. PubMed ID: 28456825
[TBL] [Abstract][Full Text] [Related]
9. Elevation of serum apelin-13 associated with proliferative diabetic retinopathy in type 2 diabetic patients.
Du JH; Li X; Li R; Xu L; Ma RR; Liu SF; Zhang Z; Sun HZ
Int J Ophthalmol; 2014; 7(6):968-73. PubMed ID: 25540748
[TBL] [Abstract][Full Text] [Related]
10. Low intravitreal angiopoietin-2 and VEGF levels in vitrectomized diabetic patients with simvastatin treatment.
Tuuminen R; Sahanne S; Loukovaara S
Acta Ophthalmol; 2014 Nov; 92(7):675-81. PubMed ID: 24506800
[TBL] [Abstract][Full Text] [Related]
11. TGF-β Serum Levels in Diabetic Retinopathy Patients and the Role of Anti-VEGF Therapy.
Bonfiglio V; Platania CBM; Lazzara F; Conti F; Pizzo C; Reibaldi M; Russo A; Fallico M; Ortisi E; Pignatelli F; Longo A; Avitabile T; Drago F; Bucolo C
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33334029
[TBL] [Abstract][Full Text] [Related]
12. Tumour necrosis factor α-308 G/a and -238 G/a polymorphisms as predicator of diabetic retinopathy in Egyptians.
Moemen LAAA; El Shahat Ebeid M; A Abdelazeem A; Kenawy M Kenawy M; M Osman Z
Arch Physiol Biochem; 2023 Oct; 129(5):1143-1151. PubMed ID: 33910435
[TBL] [Abstract][Full Text] [Related]
13. Association study of HIF-1α rs11549465 and VEGF rs3025039 genetic variants with diabetic retinopathy in Egyptian patients: crosslinks with angiogenic, inflammatory, and anti-inflammatory markers.
Mohamed MK; Atef AA; Moemen LA; Abdel Azeem AA; Mohalhal IA; Taha AM
J Genet Eng Biotechnol; 2022 Aug; 20(1):122. PubMed ID: 35969320
[TBL] [Abstract][Full Text] [Related]
14. Vascular responsiveness in type 2 diabetes mellitus (T2DM).
Blum A; Socea D; Sirchan R
QJM; 2016 Dec; 109(12):791-796. PubMed ID: 27289111
[TBL] [Abstract][Full Text] [Related]
15. Serum microRNA-221 as a biomarker for diabetic retinopathy in patients associated with type 2 diabetes.
Liu HN; Li X; Wu N; Tong MM; Chen S; Zhu SS; Qian W; Chen XL
Int J Ophthalmol; 2018; 11(12):1889-1894. PubMed ID: 30588418
[TBL] [Abstract][Full Text] [Related]
16. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N
Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
[TBL] [Abstract][Full Text] [Related]
17. Serum fetuin-A levels are independently correlated with vascular endothelial growth factor and C-reactive protein concentrations in type 2 diabetic patients with diabetic retinopathy.
Zhou ZW; Ju HX; Sun MZ; Fu QP; Chen HM; Ji HB; Ji F; Jiang DM
Clin Chim Acta; 2016 Apr; 455():113-7. PubMed ID: 26851648
[TBL] [Abstract][Full Text] [Related]
18. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
Nadar SK; Blann A; Beevers DG; Lip GY
J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
[TBL] [Abstract][Full Text] [Related]
19. Role of NF-κB activation and VEGF gene polymorphisms in VEGF up regulation in non-proliferative and proliferative diabetic retinopathy.
Choudhuri S; Chowdhury IH; Das S; Dutta D; Saha A; Sarkar R; Mandal LK; Mukherjee S; Bhattacharya B
Mol Cell Biochem; 2015 Jul; 405(1-2):265-79. PubMed ID: 25956512
[TBL] [Abstract][Full Text] [Related]
20. Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1.
Caine GJ; Blann AD; Stonelake PS; Ryan P; Lip GY
Eur J Clin Invest; 2003 Oct; 33(10):883-90. PubMed ID: 14511360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
